瑞金海南医院以制度创新为引擎，助力乐城打造医疗开放新高地 身在乐城，链接全球前沿医疗资源 上海瑞金医院专家远程操控海南医院的手术机器人，为患者切除胰体尾。图为瑞金海南医院手术室现 场。海南日报全媒体记者 袁琛 摄 海南日报全媒体见习记者 王子豪 一个蓬勃生长的"医疗特区"，蕴含着多大的发展潜力?一座百年传承的医学殿堂，激荡着多么澎湃的创新 活力?当二者在海南自贸港这片热土上相遇，答卷便在上海交通大学医学院附属瑞金医院海南医院(以下简称 瑞金海南医院)的创新实践中缓缓铺开。 瑞金海南医院是海南省政府批准建设的国家和省级重点项目，是乐城先行区唯一的公立医疗机构，于 2021年12月18日启动试运行，2022年3月18日实现医疗全流程贯通，2022年10月18日获批第四批国家区域医疗 中心建设项目。 "瑞金海南医院作为国家区域医疗中心建设的'先行者'，深深植根于海南自贸港这片充满机遇的沃 土。"近日，上海交通大学医学院附属瑞金医院副院长，上海交通大学医学院附属瑞金医院海南医院党委书 记、院长顾志冬表示，瑞金海南医院正以制度创新为引擎，以人才建设为基石，以产业联动为蓝图，全力打 造一个立足海南、辐射全国乃至东南亚的国 ...

Core Insights - The construction of Beijing's "Two Zones" (National Service Industry Expansion Pilot Zone and Free Trade Pilot Zone) has shown significant progress over the past five years, enhancing the city's capacity to attract foreign investment and support enterprises going global [1] Legal Environment Optimization - Beijing has approved the establishment of the Beijing International Law and Business Integration Demonstration Zone, covering 7.04 square kilometers in the CBD, focusing on international business cooperation and overseas service environments [2] - The region hosts over 30% of the city's legal service institutions and has established an international commercial arbitration center, enhancing legal support for businesses [2] - The initiative aims to attract global high-end resources and provide high-quality, international legal and business services to foster economic development in the capital [2] Data Facilitation - The Beijing CBD Service Station has launched a "online + offline" dual service model to assist companies with data compliance and cross-border data flow [3] - Since its operation began in 2024, the service station has supported over 50 companies across various sectors, including pharmaceuticals and banking, in meeting their cross-border data service needs [3] - Future plans include hosting specialized sessions on data security and compliance to further enhance companies' capabilities in data export [3] Rare Disease Medication Accessibility - Beijing has initiated the country's first pilot zone for rare disease medication assurance, exploring clinical application models for imported drugs not registered in China [4] - From April 2024 to July 2025, the Beijing Children's Hospital has successfully applied for temporary imports of a rare disease medication, with a total of 4,460 units approved within an average of 40 days [4] - This efficient approval process has transformed the previous situation of patients waiting for medication, ensuring continuous access to necessary drugs for rare disease patients [4] Global Innovation Drug Market - The pilot zone model in Beijing has demonstrated the convenience of the entire process from diagnosis to medication for rare disease patients, attracting attention from foreign enterprises [5] - The model has highlighted the potential of the Chinese market for global innovative drugs, providing a replicable experience for the registration and use of these drugs in China [5] - The successful promotion of this model is expected to accelerate the entry of global innovative drugs into the Chinese market [5]